Paclitaxel

Give your body the advantage for the fight ahead. Info on Neulasta®. (Sponsored Link)
http://www.Neulasta.com/

 

Avastin ® (bevacizumab)

The official website for Avastin ® from Genentech. Learn more. (Sponsored Link)
http://www.Avastin.com/

 

Buy Cancer Meds Here

Prescription required from your MD. Free shipping and Extra 5% off now! (Sponsored Link)
http://www.prescriptiongiant.com/

 

Paclitaxel for Research

99.5% pure, microtubule stabilizer See competitors' purity/prices here (Sponsored Link)
http://LCLabs.com/

 

Paclitaxel supplier

Purity 99%+, bulk ingredients. competitive price, prompt delivery (Sponsored Link)
http://www.sciphar.com/

 

Synthesis and antitumor activity of peptide-paclitaxel conjugates.

Home / Pharmaceutical Reports / Pharmaceutical report sourcer ... Synthesis and antitumor activity of peptide-paclitaxel conjugates. ... Paclitaxel conjugates showed greater solubility in water than...
http://www.leaddiscovery.co.uk/articles/17787026/

 

Oncology Medical News about Ovarian Carcinoma; Paclitaxel

Oncology / Become a Member Today! Register / Email / Password / Remember me ... Click the title below to leave the MDLinx Network and go to the Journal's Website Improved Survival with Single-Agent Paclitaxel...
http://www.mdlinx.com/HemeOncLinx/news-article.cfm/1806432

 

Hyaluronic acid-paclitaxel: antitumor efficacy aga...[Neoplasia. 2007] - PubMed Result

NCBI ... Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. ... Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted...
http://www.ncbi.nlm.nih.gov/pubmed/17603630/

 

Standard therapy plus paclitaxel improves early breast cancer survival - NeLM

About the NeLM | / Help & Support | / Site Feedback | / Update Newsletter Subscription ... Compared to FEC alone, FEC-paclitaxel reduced the risk of relapse by 23% (HR= 0.77, 95% CI = 0.62 to 0.95; P =0 .022). ... Both...
http://www.nelm.nhs.uk/en/NeLM-Area/News/494717/494747/494755/

 

Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma

The Cochrane Collaboration / Cochrane Reviews ... Paclitaxel is derived from Yews, and used for several cancers. ... Paclitaxel has become a standard drug used in a number of common cancers. ... To...
http://www.cochrane.org/reviews/en/ab003911.html

 

Abstract |Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells

Skip to main content / Log on / register / BioMed Central home | / Journals A-Z | / Feedback | / Support | / My details / Home | ... Recent data has shown that overexpression of Aurora-A can confer resistance to the taxane...
http://www.translational-medicine.com/content/6/1/79/abstract

 

HON - News : Paclitaxel Plus Chemo Improves Outcomes in Early Breast Cancer

What is it? Speech: / HONcode sites All Web sites HONselect News Conferences Images / Themes: / A B C D E F G H I ... TUESDAY, May 27 (HealthDay News) -- Adding paclitaxel to standard chemotherapy improved disease-free...
http://www.hon.ch/News/HSN/615816.html

 

The Biotech Weblog: Cell Therapeutics and Novartis Co-Develop Poliglumex Paclitaxel

... Once inside the tumor cell, enzymes metabolize the protein polymer, releasing the paclitaxel chemotherapy. ... Since the drug is trapped within the tumor, these cells are exposed to a significantly higher dose of...
http://www.biotech-weblog.com/50226711/cell_therapeutics_and_novartis_codevelop_poliglumex_paclitaxel.php

 

Combination of bryostatin and paclitaxel for treating cancer - Patent 7045495

SEARCH: ... 3. The method of claim 1, wherein paclitaxel is administered for a duration of 24 hours. 4. ... 5. The method of claim 1, wherein paclitaxel is administered subsequent to bryostatin. ... In...
http://www.freepatentsonline.com/7045495.html

 

Taxanes in Cancer Treatment

... Like most cancer drugs, paclitaxel has side effects that can be serious. ... Paclitaxel can also cause temporary damage to the bone marrow. ... The FDA approved the semi-synthetic form of...
http://cancerweb.ncl.ac.uk/cancernet/600715.html

 
< | 1 | 2 | 3 | 4 | 5 | 6 | 7 | >